IntroGene B.V. – Trademark Portfolio
Entity Type: 03
IntroGene B.V. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ADVAC. The owner is based in 2333 AL Leiden.
72, Wassenaaxseweg
2333 AL Leiden , NL
Showing of trademarks Trademarks
Trademark Classifications
IntroGene B.V.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does IntroGene B.V. have?
IntroGene B.V. has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 6 cancelled.
What trademark classes does IntroGene B.V. file in?
IntroGene B.V. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are IntroGene B.V.'s most well-known trademarks?
IntroGene B.V.'s registered trademark portfolio includes well-known marks such as ADVAC. These are among 1 currently registered trademark in the portfolio.
What is IntroGene B.V.'s trademark registration success rate?
IntroGene B.V. has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.